Gene · 286
Papers2,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a shared blood-brain transcriptomic signature in Parkinson's disease using bioinformatic and network pharmacology approaches. | Neuroscience | 2026 | 42826760 | PubTator, text mining | PubMed |
| Clinical characteristics, genotype-phenotype correlation, and prognostic follow-up of 48 Chinese children with hereditary spherocytosis. | Front Med (Lausanne) | 2026 | 42819045 | PubTator, text mining | PubMed |
| Molecular Distinctions, Diagnosis, and Mechanism-Based Therapies in Lipedema and Obesity. | Curr Issues Mol Biol | 2026 | 42793248 | PubTator, text mining | PubMed |
| Capsaicin and cinnamaldehyde as topical transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 agonists in humans: Formulation, stability, and pharmacodynamic evaluation. | J Pharmacol Exp Ther | 2026 | 42772018 | PubTator, text mining | PubMed |
| Regulation of transient receptor potential ankyrin-1 agonist-induced airway epithelial cell injury and repair by protein kinase C and p38 mitogen-activated kinase. | Mol Pharmacol | 2026 | 42759295 | PubTator, text mining | PubMed |
| Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis. | Mol Ther Nucleic Acids | 2026 | 42667096 | PubTator, text mining | PubMed |
| miR-486-5p suppresses autophagy in hepatocellular carcinoma via activation of the AKT/mTOR signalling pathway. | Mol Biomed | 2026 | 42635933 | PubTator, text mining | PubMed |
| Novel 1,3,5-triazine-based TRPA1 activators alleviate pro-fibrotic response in human lung fibroblasts. | Eur J Pharmacol | 2026 | 42601007 | PubTator, text mining | PubMed |
| Alzheimer's Disease DNA Methylation Index (AD-DMI) and its Association with Late-Life Cognitive Function. | NPJ Dement | 2026 | 42583477 | PubTator, text mining | PubMed |
| Case Report: A research on a case of hereditary spherocytosis with idiopathic pulmonary hemosiderosis. | Front Pediatr | 2026 | 42558654 | PubTator, text mining | PubMed |
| Molecular determinants of functional voltage-gated sodium (Nav) channel diversity in mammalian central neurons. | J Physiol | 2026 | 42555659 | PubTator, text mining | PubMed |
| Deep intronic ANK1 variants causing pseudo-exon inclusion in hereditary spherocytosis: Whole-genome sequencing and functional assessment. | Br J Haematol | 2026 | 42461232 | PubTator, text mining | PubMed |
| High-efficiency 14-plex cSNP SNaPshot assay for forensic peripheral blood identification. | BMC Genomics | 2026 | 42436368 | PubTator, text mining | PubMed |
| Structural insights into TRPA1 and TRPV1 modulation by flavonoid glycosides from licorice for cough relief. | Phytomedicine | 2026 | 42335638 | PubTator, text mining | PubMed |
| Resolving a Complex Neonatal Phenotype by Rapid Trio Whole-Genome Sequencing: A De Novo 11q14.3-q22.3 Deletion and a Splicing-Altering Synonymous ANK1 Variant. | J Clin Lab Anal | 2026 | 42311136 | PubTator, text mining | PubMed |
| A novel ANK1 gene mutation associated with hereditary spherocytosis: a case report. | Front Pediatr | 2026 | 42290731 | PubTator, text mining | PubMed |
Differential DNA methylation in blood as potential mediator of the association between ambient PM2.5 and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort. | Mol Psychiatry | 2026 | 42270761 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis-based Mendelian randomization identifies association of DNA repair-related genes with oral cancer. | Cancer Biomark | 2026 | 42257465 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Ferroptosis‑Related Genes in Sepsis: An Integrated Bioinformatics and Experimental Study. | Curr Mol Med | 2026 | 42257259 | PubTator, text mining | PubMed |
| A novel heterozygous mutation in ANK1 solves a mystery of a patient with hyperbilirubinemia and splenomegaly. | Pak J Med Sci | 2026 | 42257088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/286/papers